Advanced Search
Contact | Corporate | Help

BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab

Sponsors:
  • National Surgical Adjuvant Breast and Bowel Project (NSABP)
  • Cancer International Research Group
  • Hoffmann-La Roche
  • Genentech
Phases:
  • Phase III
IndicationsAcronym:
BETH
  • Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: Docetaxel
  • Drug: Trastuzumab
  • Drug: Carboplatin
  • Drug: Bevacizumab
  • Drug: 5-Fluorouracil
  • Drug: Epirubicin
  • Drug: Cyclophosphamide
Enrollment:
3500

Additional information about NCT00625898.


SourceSolution © 2008-2012